Prevention of infective endocarditis: Guidelines from the American Heart Association
Walter R. Wilson(WinnMed), David T. Durack(American Heart Association), Kathryn A. Taubert(Brigham and Women's Hospital), Matthew E. Levison, Robert O. Bonow(Northwestern University), David C. Goff(American Heart Association), Patricia Ferrieri, Peter B. Lockhart(Carolinas Medical Center), Jane W. Newburger(Greenville College), Larry M. Baddour(Mayo Clinic), Ann F. Bolger, Christopher H. Cabell(Duke Medical Center), Jane C. Burns(University of California San Diego), Michael A. Gerber(Gerber Technology (United States)), Thomas J. Pallasch(Pallas (Germany)), Anne H. Rowley(Northwestern University), Michael H. Gewitz(American Heart Association), Timothy Gardner(American Heart Association), Brian L. Strom(University of Pennsylvania), Stanford T. Shulman, Robert S. Baltimore(American Heart Association), Lloyd Y. Tani(American Heart Association), Masato Takahashi(National Hospital Organization Hokkaido Medical Center)
Cited by 484
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k